Novus Acquisition & Development Corp. Makes Key Executive Appointment
11 June 2014 - 8:34AM
Marketwired
Novus Acquisition & Development Corp. Makes Key Executive
Appointment
MIAMI, FL--(Marketwired - Jun 10, 2014) - Novus Acquisition
& Development Corp (OTC Pink: NDEV) (PINKSHEETS: NDEV) has
appointed Andrea Lopez, MSM, AHFI as an Executive Board Member and
the new CEO for its Medical Marijuana "MMJ" subsidiary Novus
Medical Group, Inc. d/b/a Novus MedPlan, in which she will lead the
company into healthcare medical plan and health insurance related
services.
Ms. Lopez's fifteen year tenure of global operational experience
has included many facets of compliance and roll out of the
healthcare delivery processes. Specifically, creating and
maintaining health care policies under the performance standards
and scrutiny of Medicare, and Fortune 500 Companies. She is an
active member of the Global Healthcare Anti-Fraud Network, the
National Health Care Anti-Fraud Association, the European
Healthcare Fraud & Corruption Network, and the Health Care
Compliance Association.
As a member of the Board of Directors and CEO of Novus Medical
Group, Inc. d/b/a Novus MedPlan, Ms. Lopez will develop a medical
plan putting Novus on the path of a Health Care Insurance program
called the "MedPlan Program". The MedPlan Program will seek to
deliver a health insurance format to patients interested in using
medical marijuana in the states where it is legal.
Frank Labrozzi, Novus' CEO states, "After reviewing Ms Lopez's
credentials, especially her tenure at International SOS, Express
Scripts and PCS (now owned by Caremark), where she developed and
led enterprise-wide efforts at the executive level, rolled out
global Health Care programs with tight internal controls, and
detailed policies and procedures to mitigate risk, we knew her
experience would prove invaluable to our team."
Andrea received both a Master of Science in Security Management
(MSM) and a Bachelor of Science degree in Criminal Justice
Administration from the prestigious Bellevue University. We welcome
her to the Novus family.
About Novus Novus is comprised of seasoned Wall Street veterans
that have focused its business model in the healthcare portion of
the medical cannabis industry. Management and its proposed future
Board of Directors areas of expertise will diversify in Healthcare,
Physicians Education, Pharma R&D, Compliance and Business
Development. NDEV will work as an outside developer's and since MMJ
is not Federally approved it will not cultivate, handle, transport
grow, extract, dispense put up for sale, put on the market, vend,
deliver, supply, circulate, trade, cannabis or any substances that
violates the United States law or the Controlled Substances Act,
nor does it intend to do so in the future and will continue to
follow state and federal laws.
For Investor Relations contact: Main Tel: (855) 422-4463 Email:
info@bcginfo.com Contact Novus Gary F. Labrozzi CEO 305-467-6699
Website: www.ndev.biz or www.novusqc.com Email: Frank@ndev.biz
Novus Acquisition and De... (PK) (USOTC:NDEV)
Historical Stock Chart
From Jan 2025 to Feb 2025
Novus Acquisition and De... (PK) (USOTC:NDEV)
Historical Stock Chart
From Feb 2024 to Feb 2025
